Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nickel

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
Journal of Biomechanics|March 16, 2021
Obstacle avoidance training in virtual environments leads to limb-specific locomotor adaptations but not to interlimb transfer in healthy young adultsA Weber, D Friemert, U Hartmann, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2000
Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patientsS Dhar, J Gullbo, K Csoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 1998
Gsalpha-selective G protein antagonistsM Hohenegger, M Waldhoer, W Beindl, et al.
Progress in Brain Research|November 7, 1999
Novel ligands for P2 receptor subtypes in innervated tissuesG Lambrecht, S Damer, B Niebel, et al.
Cardiology Research|April 22, 2024
Insights Into Differences in Pulmonary Hemodynamics in Hispanic Patients With Pulmonary Arterial HypertensionKahtan Fadah, Kedzie Arrington, Seyed Khalafi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 14, 2014
Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damageJung Wook Park, Kwangok P Nickel, Alexandra D Torres, et al.
Cardiovascular and Interventional Radiology|February 11, 2014
Percutaneous computer tomography-guided ethanol sympathicolysis for the treatment of resistant arterial hypertensionF Streitparth, B Gebauer, P Nickel, et al.
Cardiovascular & Hematological Disorders Drug Targets|January 31, 2025
Low-dose Systemic Tissue-type-plasminogen-activator Compared to Conventional Anti-coagulation for the Treatment of Intermediate-high Risk Pulmonary EmbolismAlan De la Rosa, Adrian Rojas Murguia, Michael J Brockman, et al.
Respiratory Research|November 21, 2013
Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertensionNils P Nickel, Ralf Lichtinghagen, Heiko Golpon, et al.
Arzneimittel-Forschung|August 1, 1986
[Potential filaricides. Suramin analogs]P Nickel, H J Haack, H Widjaja, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Journal of Biomechanics|March 16, 2021
Obstacle avoidance training in virtual environments leads to limb-specific locomotor adaptations but not to interlimb transfer in healthy young adultsA Weber, D Friemert, U Hartmann, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2000
Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patientsS Dhar, J Gullbo, K Csoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 1998
Gsalpha-selective G protein antagonistsM Hohenegger, M Waldhoer, W Beindl, et al.
Progress in Brain Research|November 7, 1999
Novel ligands for P2 receptor subtypes in innervated tissuesG Lambrecht, S Damer, B Niebel, et al.
Cardiology Research|April 22, 2024
Insights Into Differences in Pulmonary Hemodynamics in Hispanic Patients With Pulmonary Arterial HypertensionKahtan Fadah, Kedzie Arrington, Seyed Khalafi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 14, 2014
Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damageJung Wook Park, Kwangok P Nickel, Alexandra D Torres, et al.
Cardiovascular and Interventional Radiology|February 11, 2014
Percutaneous computer tomography-guided ethanol sympathicolysis for the treatment of resistant arterial hypertensionF Streitparth, B Gebauer, P Nickel, et al.
Cardiovascular & Hematological Disorders Drug Targets|January 31, 2025
Low-dose Systemic Tissue-type-plasminogen-activator Compared to Conventional Anti-coagulation for the Treatment of Intermediate-high Risk Pulmonary EmbolismAlan De la Rosa, Adrian Rojas Murguia, Michael J Brockman, et al.
Respiratory Research|November 21, 2013
Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertensionNils P Nickel, Ralf Lichtinghagen, Heiko Golpon, et al.
Arzneimittel-Forschung|August 1, 1986
[Potential filaricides. Suramin analogs]P Nickel, H J Haack, H Widjaja, et al.
Pageof 15